/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

ASND — Ascendis Pharma A/S Ordinary Share

Nasdaq

Ascendis Pharma A/S Ordinary Share

Back to Screener
$227.87
+0.56(+0.25%)
O
227.63
H
229.02
L
225.20
V
641.43K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Ascendis Pharma A/S Ordinary Share Statistics

Total Valuation

Market Cap$14.84B
Enterprise Value$14.82B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding65.78M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio23.37
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio307.93
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ratio1,958.40
PEG Ration/a

Enterprise Valuation

EV / Earnings235.52
EV / Salesn/a
EV / EBITDA636.19
EV / EBIT776.92
EV / FCF-1,919.71

Financial Position

Current Ratio1.00
Quick Ration/a
Debt / Equity0.79
Debt / EBITDA1.66
Debt / FCF-5.00
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)128.97%
Return on Assets (ROA)31.42%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$52,930
Employee Count1,189
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax-$67.75M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+13.39%
50-Day Moving Average$248.70
200-Day Moving Average$235.57
Relative Strength Index (RSI)26.78
Average Volume (20 Days)906,791

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$22.91M
Operating Income$24.81M
Pretax Income-$48.18M
Net Income$62.93M
EBITDA$23.30M
EBIT$19.08M
Earnings Per Share$9.75

Balance Sheet

Cash & Cash Equivalents$57.28M
Total Debt$38.61M
Net Cash$18.67M
Net Cash Per Share$0.28
Equity (Book Value)$48.80M
Book Value Per Share$0.74
Working Capital-$442.30K

Cash Flow

Operating Cash Flow$7.58M
Capital Expenditures$959.00K
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$7.72M
FCF Per Share$-0.12

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield4.28%
FCF Yield-0.05%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$146.25
Lynch Upside-35.82%
Graham Number$12.74
Graham Upside-94.41%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a